Curanex Pharmaceuticals Inc Common Stock (CURX) — Cash Flow Reinvestment Rate
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $3.34K. See CURX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Curanex Pharmaceuticals Inc Common Stock Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Curanex Pharmaceuticals Inc Common Stock across 1 annual periods. For the full cash flow conversion analysis, see Curanex Pharmaceuticals Inc Common Stock cash flow conversion.
Annual Cash Flow Reinvestment Rate for Curanex Pharmaceuticals Inc Common Stock (2022–2022)
Year-by-year capital reinvestment analysis for Curanex Pharmaceuticals Inc Common Stock. See CURX financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $3.34K | $0.00 | — |